An extra test on the first follow-up screening test after treatment will be carried out by the pathology laboratory as part of the national cervical screening programme. This `test of cure’ will test for High Risk Human Papilloma Virus. If detected, patients will be referred back to the Colposcopy Unit for further assessment.